R&D

Court Ruling on 'Biosimilars' Sets Stage for More Drug Acquisitions
TheStreet.com
Sun, 07/30/17 - 09:44 am
biosimilars
M&A
R&D
Supreme Court
Alexion leaves Moderna, others behind in R&D shake-up
BioPharma Dive
Sat, 07/29/17 - 09:50 am
Alexion
Moderna Therapeutics
Arbutus BioPharma
Blueprint Medicines
R&D
Merck admits cyberattack is having an impact on research, manufacturing — we’re just not sure how big
Endpoints
Fri, 07/28/17 - 10:47 pm
Merck
R&D
cybersecurity
cyberattack
Diabetes Crisis Continues To Rage, But Biopharma's Response Is Tepid
Forbes
Thu, 07/27/17 - 09:55 am
diabetes
R&D
Alexion joins the R&D reorganization gala, pruning a slate of projects and revving up new deals
Endpoints
Thu, 07/27/17 - 09:49 am
Alexion
R&D
reorganization
ALXN1101
ALXN6000
Takeda, BioSurfaces collab on GI drug-delivery devices
Drug Delivery Business News
Wed, 07/26/17 - 10:08 am
Takeda
BioSurfaces
GI disease
drug delivery
R&D
GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research
Endpoints
Wed, 07/26/17 - 09:52 am
GSK
reorganization
Emma Walmsley
Pharma CEOs
R&D
cancer
The Startling History Behind Merck's New Cancer Blockbuster
Forbes
Wed, 07/26/17 - 09:51 am
Merck
Keytruda
cancer
R&D
Organon
Lilly puts two-thirds of midphase cancer pipeline up for sale in major shake-up of R&D priorities
Fierce Biotech
Tue, 07/25/17 - 10:27 am
Eli Lilly
M&A
oncology
R&D
Biogen lays out a plan to “streamline” ops and add $400M to fund neurosciences R&D, growth
Endpoints
Tue, 07/25/17 - 08:29 am
Biogen
R&D
restructuring
A new wave of pharma mergers could put innovative drugs in the pipeline
Stat
Mon, 07/24/17 - 11:07 am
M&A
R&D
innovation
Sanofi offers Ablynx billions of biobucks for nanobody partnership
Fierce Biotech
Thu, 07/20/17 - 11:26 am
Sanofi
Ablynx
nanobodies
R&D
Emergo survey: Medical device R&D spending expected to rise through 2018
Emergo
Thu, 07/20/17 - 11:16 am
devices
R&D
Eli Lilly buys itself an antibody R&D platform from Tillman Gerngross’s Adimab
Endpoints
Wed, 07/19/17 - 09:28 am
Eli Lilly
R&D
antibodies
Adimab
King cancer: The top 10 therapeutic areas in biopharma R&D
Endpoints
Tue, 07/18/17 - 10:49 pm
R&D
cancer
neurology
infection
immunology
cardiovascular disease
diabetes
Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report
Fierce Pharma
Tue, 07/18/17 - 11:36 am
Takeda
R&D
drug reps
layoffs
reorganization
vaccines
Boston
Big Pharma Share Buybacks Not Impacting R&D Budgets
Forbes
Tue, 07/18/17 - 11:31 am
Big Pharma
share repurchase
R&D
Precise Medicines: Matching Patients with the Most Effective Drugs
Elsevier
Sun, 07/16/17 - 03:43 pm
patients
precision medicine
R&D
GlaxoSmithKline woos Pfizer medicinal sciences chief Tony Wood to high-level R&D job
Endpoints
Fri, 07/14/17 - 07:52 am
GSK
Pfizer
Tony Wood
R&D
Advantages and Challenges of Using Social Media for Pharma R&D
Elsevier
Thu, 07/13/17 - 05:41 pm
social media
R&D

Pages